Management of an Acute Asthma Attack in Adults (aged 16 years and older)

Objectives

Improve the quality, safety, consistency and efficiency of acute asthma care for adults aged 16 years and over in Ireland, using a national evidence-based guideline that supports healthcare professionals, policymakers and acute-service planners across pre-hospital, primary, secondary and specialist settings.[1][2]The guideline covers assessment, severity recognition, treatment, referral, admission, discharge, follow-up, pregnancy and patient education, while excluding children, stable difficult or severe asthma, and patients whose primary respiratory diagnosis is chronic obstructive pulmonary disease or cystic fibrosis.[3][2]

• Reduce asthma morbidity, avoidable emergency attendances, hospital admissions and preventable deaths, while improving asthma control, quality of life and patient experience.[4][5]
• Standardise acute-care pathways across general practice, out-of-hours services, paramedic services, emergency departments and acute hospitals, including clear criteria for assessment, referral, admission, discharge and follow-up.[4][6]
• Promote objective assessment of exacerbation severity through clinical findings, peak expiratory flow or spirometry, oxygen saturation, respiratory rate and pulse, so that severe, life-threatening and near-fatal attacks are recognised promptly.[7][8]
• Provide prompt, evidence-based treatment, including early high-dose inhaled beta₂-agonists, oxygen for hypoxaemia, systemic corticosteroids and escalation to intensive care where clinically indicated.[9][10]
• Strengthen prevention after acute attacks through inhaler-technique support, adherence review, written personalised action plans, trigger and risk-factor management, smoking cessation support and structured clinical follow-up.[11][6]
• Address fatal-asthma risk by recognising severe disease alongside behavioural, social or psychosocial risks, and maintain indefinite specialist supervision for people who have experienced near-fatal asthma.[12]
• Ensure that pregnant patients receive appropriate acute asthma management, with particular attention to maternal and fetal oxygenation and referral to hospitals with respiratory and intensive-care expertise when needed.[13][14]

Implementation

Deliver the guideline through an integrated national model linking primary care, out-of-hours and urgent-care services, paramedic services, emergency departments, acute hospitals, respiratory specialists and maternity services.[4][15]Governance combines national clinical leadership, evidence review and quality assurance with local hospital implementation leads, care bundles, education, audit and structured follow-up.[1][16][17]

• Coordinate national development through the Health Service Executive National Clinical Programme for Asthma, supported by a multidisciplinary Guideline Development Group, Clinical Advisory Group and National Clinical Effectiveness Committee quality assurance.[3][18]
• Adapt international evidence from the British Thoracic Society and Scottish Intercollegiate Guidelines Network and the Global Initiative for Asthma to the Irish health-service context, using systematic review, the ADAPTE process and Appraisal of Guidelines for Research and Evaluation II quality assessment.[3][18]
• Establish a local implementation team and lead at each hospital site, with a senior clinical lead in each acute hospital admissions unit responsible for guideline conformity, records, audit processes and outcomes.[16][17]
• Implement standard treatment protocols and care bundles in hospitals and primary care, retain bundles in patient records, and use discharge communication templates, management plans and emergency-care audit tools to support consistent practice.[16][19]
• Train clinical staff through online asthma education, respiratory Clinical Nurse Specialist workshops, continuing professional development, consultant-led teaching and undergraduate, postgraduate and primary-care education.[16][20][21]
• Provide accessible emergency assessment and treatment locally, distinguish patients requiring hospitalisation from those suitable for community care, and use inhalers with spacer devices instead of routine nebuliser treatment where clinically appropriate.[22][17]
• Arrange general-practitioner review within two working days after discharge from out-of-hours, emergency department or hospital care, and provide specialist medical or nurse-led follow-up for one year after hospital admission until asthma is stable.[4][6]
• Engage general practitioners, practice nurses, pharmacists, pre-hospital emergency care practitioners, emergency and acute medicine teams, respiratory specialists, audit services, patient organisations and relevant professional bodies in implementation, review and updating.[23][19]
• Monitor implementation through local records, care-bundle review and audit, including the percentage of primary- and secondary-care nurses trained by the National Asthma Programme and annual asthma deaths.[23]
• Review the evidence base periodically and formally review the guideline three years after its November 2015 publication, with updates subject to National Clinical Effectiveness Committee approval.[16]
• Resource implementation principally through staff training, estimated at 193,104 euros, largely representing opportunity costs.[4]The source estimates annual savings of 179,978 euros from reduced emergency-department nebuliser use and 1.38 million euros from improved specialist or asthma-nurse-led follow-up associated with fewer attendances and a 20% reduction in admissions.[22]

Monitoring & Evaluation

Monitoring and accountability combine national guideline quality assurance, local clinical audit, structured documentation, follow-up requirements and bedside assessment. The National Clinical Effectiveness Committee provides a framework for prioritising and quality-assuring clinical guidelines and audits, and is expected to report periodically on implementation, impact and National Clinical Audit performance.[1][24]Guideline development also used systematic evidence review, independent appraisal and external review processes.[3][18][16]

• Maintain local records, audit processes and outcome data in each acute hospital admissions unit under a designated senior clinical lead, and use local care bundles to promote adherence to acute-asthma best practice.[22][17]
• Audit emergency asthma care using checks on objective assessment, vital signs, oxygen saturation, peak expiratory flow, inhaler technique, treatment, psychosocial risks, discharge education, action plans and follow-up communication.[25][26]
• Retain treatment bundles and structured proformas in patient records to support process evaluation, audit, data collection on quality and outcomes, and respiratory-service follow-up.[16][27][23]
• Monitor acute clinical deterioration through symptoms, peak expiratory flow or forced expiratory volume in one second, oxygenation, arterial blood gases, carbon dioxide, respiratory effort, pulse, respiratory rate and mental state.[9][10][28][29]
• Use continuous monitoring, including pulse oximetry and cardiac monitoring, for life-threatening asthma, and continuous fetal monitoring for severe or life-threatening asthma during pregnancy.[30][31][14]
• Track post-discharge care through general-practitioner review within two working days and specialist follow-up for one year after hospital admission or until asthma is stable.[4][6][32][33]
• Measure the proportion of primary- and secondary-care nurses trained by the National Asthma Programme and the annual number of asthma deaths as specified key performance indicators.[23]
• Use hospital admissions, emergency-department attendance, readmissions, controller-treatment appropriateness, self-management and service utilisation as outcome measures where specified.[34][35][32][33]
• Conduct periodic literature surveillance and review the guideline three years after its November 2015 publication, with updates subject to National Clinical Effectiveness Committee approval.[16]

The material does not provide a complete national indicator set, common reporting timetable, surveillance architecture, outcome targets or a detailed post-implementation evaluation methodology. It identifies anticipated reductions in admissions, emergency attendance and deaths, but these are not consistently defined as nationally reported targets.[22][36][15][17]

Costing & Financing

The economic case centres on reducing acute-care use through trained staff, evidence-based treatment, structured follow-up, self-management and integrated chronic-disease management. Acute asthma attacks in the Republic of Ireland are estimated to cost approximately 6.5 million Euro annually, with hospitalisation accounting for 20% to 25% of total costs.[4]Hospital admission and medicines are identified as major contributors to direct asthma costs.[34]

• Fund evidence review and budget-impact assessment through the National Clinical Effectiveness Committee; no external funding was requested or received for guideline development.[3][18]
• Provide structured staff training as the principal implementation cost, estimated at 193,104 Euro and described mainly as an opportunity cost.[4]The online asthma-education service-level agreement cost 29,084 Euro annually from 2011 to 2014, although this covered wider education and guideline activity and cannot be attributed solely to the acute-asthma guideline.[20]
• Recognise training-related costs for Clinical Nurse Specialist workshop delivery, nurse attendance, out-of-hours staff and consultant-led local teaching.[21]
• Use pressurised metered-dose inhalers with spacers where clinically suitable, as this route is described as the most cost-effective delivery method and may be less expensive than wet nebulisation.[37][38][35]
• Estimate annual savings of 179,978 Euro from reducing Emergency Department nebuliser use and 1.38 million Euro from improved specialist- or nurse-led post-discharge follow-up associated with fewer attendances and admissions.[22][33]
• Budget an estimated 440,920 Euro annually for specialist follow-up, comprising medical outpatient and nurse-specialist clinics for patients admitted with acute asthma.[33]
• Recognise that broader implementation measures, including spacers, medicines, peak-flow measurement and follow-up, are described as cost-neutral or linked to a wider chronic disease management model.[4][20]

Economic evidence was identified through a systematic review and converted to 2013 Irish values using national Consumer Price Index and Purchasing Power Parity methods where applicable.[6][17]The supplied material does not specify a dedicated overall implementation budget, financing allocation, resource-mobilisation plan, funding gap or comprehensive economic assumptions.[4][22][17][33]